8 results on '"Małgorzata Piotrowicz"'
Search Results
2. NGS analysis of collagen type I genes in Polish patients with Osteogenesis imperfecta: a nationwide multicenter study
- Author
-
Kinga Sałacińska, Iwona Pinkier, Lena Rutkowska, Danuta Chlebna-Sokół, Elżbieta Jakubowska-Pietkiewicz, Izabela Michałus, Łukasz Kępczyński, Dominik Salachna, Nina Wieczorek-Cichecka, Małgorzata Piotrowicz, Tatiana Chilarska, Aleksander Jamsheer, Paweł Matusik, Małgorzata Wilk, Elżbieta Petriczko, Maria Giżewska, Iwona Stecewicz, Mieczysław Walczak, Magda Rybak-Krzyszkowska, Andrzej Lewiński, and Agnieszka Gach
- Subjects
osteogenesis imperfecta ,connective tissue disorder ,collagen type I ,COL1A1 ,COL1A2 ,next-generation sequencing ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
Osteogenesis imperfecta (OI) is a rare genetic disorder of the connective tissue. It presents with a wide spectrum of skeletal and extraskeletal features, and ranges in severity from mild to perinatal lethal. The disease is characterized by a heterogeneous genetic background, where approximately 85%–90% of cases have dominantly inherited heterozygous pathogenic variants located in the COL1A1 and COL1A2 genes. This paper presents the results of the first nationwide study, performed on a large cohort of 197 Polish OI patients. Variants were identified using a next-generation sequencing (NGS) custom gene panel and multiplex ligation probe amplification (MLPA) assay. The following OI types were observed: 1 (42%), 2 (3%), 3 (35%), and 4 (20%). Collagen type I pathogenic variants were reported in 108 families. Alterations were observed in α1 and α2 in 70% and 30% of cases, respectively. The presented paper reports 97 distinct causative variants and expands the OI database with 38 novel pathogenic changes. It also enabled the identification of the first glycine-to-tryptophan substitution in the COL1A1 gene and brought new insights into the clinical severity associated with variants localized in “lethal regions”. Our results contribute to a better understanding of the clinical and genetic aspects of OI.
- Published
- 2023
- Full Text
- View/download PDF
3. The Use of CGH Arrays for Identifying Copy Number Variations in Children with Autism Spectrum Disorder
- Author
-
Agata Kucińska, Wanda Hawuła, Lena Rutkowska, Urszula Wysocka, Łukasz Kępczyński, Małgorzata Piotrowicz, Tatiana Chilarska, Nina Wieczorek-Cichecka, Katarzyna Połatyńska, Łukasz Przysło, and Agnieszka Gach
- Subjects
autism spectrum disorders ,neurogenetics ,copy number variation ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Autism spectrum disorders (ASDs) encompass a broad group of neurodevelopmental disorders with varied clinical symptoms, all being characterized by deficits in social communication and repetitive behavior. Although the etiology of ASD is heterogeneous, with many genes involved, a crucial role is believed to be played by copy number variants (CNVs). The present study examines the role of copy number variation in the development of isolated ASD, or ASD with additional clinical features, among a group of 180 patients ranging in age from two years and four months to 17 years and nine months. Samples were taken and subjected to array-based comparative genomic hybridization (aCGH), the gold standard in detecting gains or losses in the genome, using a 4 × 180 CytoSure Autism Research Array, with a resolution of around 75 kb. The results indicated the presence of nine pathogenic and six likely pathogenic imbalances, and 20 variants of uncertain significance (VUSs) among the group. Relevant variants were more prevalent in patients with ASD and additional clinical features. Twelve of the detected variants, four of which were probably pathogenic, would not have been identified using the routine 8 × 60 k microarray. These results confirm the value of microarrays in ASD diagnostics and highlight the need for dedicated tools.
- Published
- 2024
- Full Text
- View/download PDF
4. Coexisting Conditions Modifying Phenotypes of Patients with 22q11.2 Deletion Syndrome
- Author
-
Marta Smyk, Maciej Geremek, Kamila Ziemkiewicz, Tomasz Gambin, Anna Kutkowska-Kaźmierczak, Katarzyna Kowalczyk, Izabela Plaskota, Barbara Wiśniowiecka-Kowalnik, Magdalena Bartnik-Głaska, Magdalena Niemiec, Dominika Grad, Małgorzata Piotrowicz, Dorota Gieruszczak-Białek, Aleksandra Pietrzyk, T. Blaine Crowley, Victoria Giunta, Daniel E. McGinn, Elaine H. Zackai, Oanh Tran, Beverly S. Emanuel, Donna M. McDonald-McGinn, and Beata A. Nowakowska
- Subjects
22q11.2DS ,genomic disorder ,copy number variation ,CNV ,single nucleotide variant ,SNV ,array ,exome sequencing ,Genetics ,Genetics (clinical) - Abstract
22q11.2 deletion syndrome (22q11.2DS) is the most common genomic disorder with an extremely broad phenotypic spectrum. The aim of our study was to investigate how often the additional variants in the genome can affect clinical variation among patients with the recurrent deletion. To examine the presence of additional variants affecting the phenotype, we performed microarray in 82 prenatal and 77 postnatal cases and performed exome sequencing in 86 postnatal patients with 22q11.2DS. Within those 159 patients where array was performed, 5 pathogenic and 5 likely pathogenic CNVs were identified outside of the 22q11.2 region. This indicates that in 6.3% cases, additional CNVs most likely contribute to the clinical presentation. Additionally, exome sequencing in 86 patients revealed 3 pathogenic (3.49%) and 5 likely pathogenic (5.81%) SNVs and small CNV. These results show that the extension of diagnostics with genome-wide methods can reveal other clinically relevant changes in patients with 22q11 deletion syndrome.
- Published
- 2023
- Full Text
- View/download PDF
5. Identification of New Genetic Determinants in Pediatric Patients with Familial Hypercholesterolemia Using a Custom NGS Panel
- Author
-
Lena Rutkowska, Kinga Sałacińska, Dominik Salachna, Paweł Matusik, Iwona Pinkier, Łukasz Kępczyński, Małgorzata Piotrowicz, Ewa Starostecka, Andrzej Lewiński, and Agnieszka Gach
- Subjects
Hyperlipoproteinemia Type II ,Phenotype ,Receptors, LDL ,familial hypercholesterolemia ,genetics ,next generation sequencing ,LDLR gene ,dyslipidemia ,novel variant ,pediatric patients ,Genetics ,High-Throughput Nucleotide Sequencing ,Humans ,nutritional and metabolic diseases ,lipids (amino acids, peptides, and proteins) ,Proprotein Convertase 9 ,Child ,Genetics (clinical) ,Apolipoproteins B - Abstract
The most common form of inherited lipid disorders is familial hypercholesterolemia (FH). It is characterized primarily by high concentrations of the clinical triad of low-density lipoprotein cholesterol, tendon xanthomas and premature CVD. The well-known genetic background are mutations in LDLR, APOB and PCSK9 gene. Causative mutations can be found in 60–80% of definite FH patients and 20–30% of those with possible FH. Their occurrence could be attributed to the activity of minor candidate genes, whose causal mechanism has not been fully discovered. The aim of the conducted study was to identify disease-causing mutations in FH-related and candidate genes in pediatric patients from Poland using next generation sequencing (NGS). An NGS custom panel was designed to cover 21 causative and candidate genes linked to primary dyslipidemia. Recruitment was performed using Simon Broome diagnostic criteria. Targeted next generation sequencing was performed on a MiniSeq sequencer (Illumina, San Diego, CA, USA) using a 2 × 150 bp paired-end read module. Sequencing data analysis revealed pathogenic and possibly pathogenic variants in 33 out of 57 studied children. The affected genes were LDLR, APOB, ABCG5 and LPL. A novel pathogenic 7bp frameshift deletion c.373_379delCAGTTCG in the exon 4 of the LDLR gene was found. Our findings are the first to identify the c.373_379delCAGTTCG mutation in the LDLR gene. Furthermore, the double heterozygous carrier of frameshift insertion c.2416dupG in the LDLR gene and missense variant c.10708C>T in the APOB gene was identified. The c.2416dupG variant was defined as pathogenic, as confirmed by its cosegregation with hypercholesterolemia in the proband’s family. Although the APOB c.10708C>T variant was previously detected in hypercholesterolemic patients, our data seem to demonstrate no clinical impact. Two missense variants in the LPL gene associated with elevated triglyceride plasma level (c.106G>A and c.953A>G) were also identified. The custom NGS panel proved to be an effective research tool for identifying new causative aberrations in a genetically heterogeneous disease as familial hypercholesterolemia (FH). Our findings expand the spectrum of variants associated with the FH loci and will be of value in genetic counseling among patients with the disease.
- Published
- 2022
- Full Text
- View/download PDF
6. Psycho-social problems in patients with 22q11.2 deletion syndrome – according to subjective evaluation by parents
- Author
-
Dorota Szałowska-Woźniak, Krzysztof Zeman, Paweł Jarosz, Jarosław Paśnik, Marcin Machnia, Agnieszka Cywińska-Bernas, Eliza Pilarz, Agnieszka Moll-Maryńczak, and Małgorzata Piotrowicz
- Subjects
22q11 Deletion Syndrome ,business.industry ,Medicine ,Deletion syndrome ,In patient ,General Medicine ,business ,Psychosocial ,Clinical psychology - Published
- 2018
- Full Text
- View/download PDF
7. Basic Characteristics of Concrete Durability as the Criteria for Curing Classes Selection According to EN 13670:2009
- Author
-
Katarzyna Łaskawiec, Piotr Woyciechowski, Małgorzata Piotrowicz, and Piotr Romanowski
- Subjects
Cement ,Materials science ,Moisture ,Carbonation ,curing ,General Medicine ,Durability ,curing classes ,Compressive strength ,concrete ,durability ,Composite material ,Reinforcement ,Porosity ,Curing (chemistry) ,Engineering(all) - Abstract
In EN 13670:2009 standard: Execution of concrete structures there are general rules of moisture curing of concrete in structures. In the standard 4 classes of concrete curing are described. Determination of curing class depends on required level of compressive strength immediately after curing (percentage of required characteristic strength after 28 days). Time of curing depends on rate of strength development and concrete surface temperature. In the standard there is a lack of information about influence of curing class on concrete durability characteristics. The main condition to obtain durable concrete is proper curing regime. Not cured on improperly cured concrete has weakened surface layer. Extremely faults in curing process could lead to defects visible on the concrete surface. More often defects are latent inside the concrete and could be revealed during exploitation, leading to durability reduction. The main effect is increase of surface layer porosity (reinforcement cover) and decrease of its protective properties and tightness. Consequently worsening of mechanical properties could be observed as well as water-tightness, frost resistance, chemical aggression resistance, carbonation resistance and diffusivity of chloride. The analysis shown in the paper are the result of 3-yers long investigation conducted by authors, which main goal was to determine appropriateness and way to include durability requirements in designing of curing class according to EN 13670:2009. Thawing-freezing resistance, scaling with salts resistance, depth of water penetration under pressure and absorptivity were adopted as the basic durability factors. Concretes with different cement types, different rate of compressive strength development, air-entrained and non-air-entrained were tested. Time of curing was differentiated in the range of classes 1,3,4 following standard EN 13670:2009 requirements. Practical conclusions were formulated which allows to consider durability presumptions in technological requirements contained in concrete works specifications.
- Published
- 2015
- Full Text
- View/download PDF
8. Immune Dysregulation in Patients With Chromosome 18q Deletions—Searching for Putative Loci for Autoimmunity and Immunodeficiency
- Author
-
Anna Hogendorf, Maciej Zieliński, Maria Constantinou, Robert Śmigiel, Jolanta Wierzba, Krystyna Wyka, Anna Wędrychowicz, Anna Jakubiuk-Tomaszuk, Edyta Budzynska, Malgorzata Piotrowicz, Beata S. Lipska-Ziętkiewicz, Ewa Kaczorowska, Agata Cieślikowska, Anna Kutkowska-Kaźmierczak, Jolanta Fijak-Moskal, Monika Kugaudo, Małgorzata Kosińska-Urbańska, Agnieszka Szadkowska, Maciej Borowiec, Maciej Niedźwiecki, Piotr Trzonkowski, and Wojciech Młynarski
- Subjects
18q deletion syndrome ,immune deficiency ,type 1 diabetes ,autoimmune diseases ,thyroiditis ,T regulatory cells ,Immunologic diseases. Allergy ,RC581-607 - Abstract
IntroductionAutoimmune disorders, IgA deficiency, and allergies seem to be common among individuals with 18q deletion syndrome [OMIM 601808]. We aimed to determine the prevalence, mechanism, and genetic background of autoimmunity, immune deficiency, and allergy in a cohort of patients with 18q deletions.Material and MethodsMedical registries and social media were used to recruit the patients. Microarray oligonucleotide comparative genomic hybridization (aCGH) (Agilent, Santa Clara, CA, USA) was performed in all patients to identify size and location of chromosome 18 deletion. Clinical evaluation and medical record collection were performed in each of the study participants. The history of autoimmune disorders, severe and/or recurrent infections, and symptoms of allergy were noted. Total immunoglobulin IgG, IgA, IgM, IgE, and IgG1-4 serum levels were measured using nephelometry and ELISA methods. Lymphocyte T subset phenotyping was performed in 24 subjects from 18q del cohort. To predict the most promising candidate genes, we used the ENDEAVOUR—a free web resource for gene prioritization.Results18q deletion was confirmed by means of array CGH analysis in 27 individuals, 15 (55.6%) females and 12 males, referred to the project by specialists in medical genetics, diabetology, or pediatric endocrinology between May 2015 and December 2019. The mean age at examination was 11.8 years (min–max: 4.0–33.5). Autoimmune disorders were present in 14/27 (51.8%) of the cohort. In eight of patients, symptoms of immune deficiency coexisted with autoimmunity. Allergy was reported in nine of 27 (33.4%) patients. Over 89% of patients presented with at list one type of immunoglobulin (IgA, IgM, IgG, IgE, and IgG1-4) deficiency and eight of 25 (32%) had abnormalities in at least two major immunoglobulin (IgG, IgA, IgM) measurements (CVID-like phenotype). Patients with 18q del exhibited a significantly decreased CD4, Treg FOXP3+, TregFOXP3+Helios+, and TemCD4 cell numbers in comparison with the control groups of 24 T1DM patients and 28 healthy controls.ConclusionsPatients with 18q deletions frequently suffer from autoimmune disorders, recurrent infections, and allergy due to immune dysregulation presenting with variable antibody deficiencies and T-regulatory cell deficiency (CD4+CD25+CD127lowFOXP3+). The spectrum of speculations regarding which gene might be responsible for such phenotype ranges from single gene haploinsufficiency to deletion of a cluster of immunogenes located distally to 18q21.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.